These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27516059)

  • 61. Association of the interleukin-10 -592A/C, -1082G/A and -819T/C gene polymorphisms with type 2 diabetes: a meta-analysis.
    Li J; Wu S; Wang MR; Wang TT; Zhu JM
    Gene; 2013 Jun; 521(2):211-6. PubMed ID: 23562725
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationship Between Interleukin-10 Gene C-819T Polymorphism and Gastric Cancer Risk: Insights From a Meta-Analysis.
    Cui X; Huang Q; Li X; Liu F; Wang D; Yan D; Wang B; Yang C; Mi J; Tian G
    Med Sci Monit; 2016 Aug; 22():2839-45. PubMed ID: 27516059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies.
    Men T; Yu C; Wang D; Liu F; Li J; Qi X; Yang C; Jiang W; Wei X; Li X; Wang B; Mi J; Tian G
    Oncotarget; 2017 Jul; 8(28):45994-46005. PubMed ID: 28526808
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ASSOCIATION OF INTERLEUKIN-10 -592A>C AND -819T>C POLYMORPHISMS WITH GASTRIC CANCER RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 44 CASE-CONTROL STUDIES.
    Moghmi M; Arjmandi A; Aghili K; Jafari M; Zare-Shehneh M; Rastegar S; Abolbaghaei SM; Neamatzadeh H
    Arq Bras Cir Dig; 2019 Jan; 32(1):e1415. PubMed ID: 30624524
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ethnic differences in gastric cancer genetic susceptibility: allele flips of interleukin gene.
    Kim J; Kim Y; Lee KA
    World J Gastroenterol; 2014 Apr; 20(16):4558-65. PubMed ID: 24782608
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Roles of Cyclooxygenase-2 gene -765G > C (rs20417) and -1195G > A (rs689466) polymorphisms in gastric cancer: A systematic review and meta-analysis.
    Luo MX; Long BB; Li F; Zhang C; Pan MT; Huang YQ; Chen B
    Gene; 2019 Feb; 685():125-135. PubMed ID: 30391440
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Distinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cells.
    Holan V; Zajicova A; Javorkova E; Trosan P; Chudickova M; Pavlikova M; Krulova M
    Immunology; 2014 Apr; 141(4):577-86. PubMed ID: 24256319
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.
    Yu Z; Liu Q; Huang C; Wu M; Li G
    OMICS; 2013 Apr; 17(4):200-14. PubMed ID: 23574339
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx.
    Jin L; Sturgis EM; Cao X; Song X; Salahuddin T; Wei Q; Li G
    FASEB J; 2013 Jun; 27(6):2496-503. PubMed ID: 23430974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancer heterogeneity: origins and implications for genetic association studies.
    Urbach D; Lupien M; Karagas MR; Moore JH
    Trends Genet; 2012 Nov; 28(11):538-43. PubMed ID: 22858414
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interleukin-10-819 promoter polymorphism in association with gastric cancer risk.
    Xue H; Lin B; An J; Zhu Y; Huang G
    BMC Cancer; 2012 Mar; 12():102. PubMed ID: 22436502
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer.
    Kim J; Cho YA; Choi IJ; Lee YS; Kim SY; Shin A; Cho SJ; Kook MC; Nam JH; Ryu KW; Lee JH; Kim YW
    PLoS One; 2012; 7(1):e29643. PubMed ID: 22235320
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interleukin-10 ablation promotes tumor development, growth, and metastasis.
    Tanikawa T; Wilke CM; Kryczek I; Chen GY; Kao J; Núñez G; Zou W
    Cancer Res; 2012 Jan; 72(2):420-9. PubMed ID: 22123924
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China.
    Zeng X; Li Y; Liu T; Zhang J
    Mol Cell Biochem; 2012 Mar; 362(1-2):241-8. PubMed ID: 22081333
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased risk for gastric cancer in carriers of the lymphotoxin-α+252G variant infected by Helicobacter pylori.
    He B; Pan Y; Xu Y; Nie Z; Chen L; Gu L; Wang S
    Genet Test Mol Biomarkers; 2012 Jan; 16(1):9-14. PubMed ID: 21793721
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer.
    Liu J; Song B; Wang JL; Li ZJ; Li WH; Wang ZH
    World J Gastroenterol; 2011 Mar; 17(10):1362-7. PubMed ID: 21455338
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer.
    Szkaradkiewicz A; Karpiński TM; Drews M; Borejsza-Wysocki M; Majewski P; Andrzejewska E
    J Biomed Biotechnol; 2010; 2010():901564. PubMed ID: 20445748
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mendelian randomization in the era of genomewide association studies.
    Sleiman PM; Grant SF
    Clin Chem; 2010 May; 56(5):723-8. PubMed ID: 20224045
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.